Waiting for new medicines in Canada, Europe and the United States 2016-2021

The study compared the availability and wait for new medicines in Canada, the European Union and the United States. It examined new drug launches, regulatory approvals, and insurance coverage during the years 2016-2021.

Read the study

Previous
Previous

SHIFT: Why do cancer patients have to jump through hoops to get life-saving medication?

Next
Next

Canada’s hospital capacity crisis will remain long after the pandemic is over